摘要
随着生活方式的改变及人均寿命的延长,我国心血管疾病的发病率进入快速增长期,2006年我国心血管疾病患者约为2200万,其中心力衰竭患者约为420万。心血管疾病不仅文寸社会及家庭造成了严重影响,还是现阶段人类死亡的首要原因。心力衰竭是多种心血管疾病终末期的一种综合征,同时也是心血管疾病死亡的主要原因。随着循证医学的发展,近年多个国家相继修改或出台心力衰竭诊治指南(以下简称指南),
出处
《河北医药》
CAS
2011年第22期3466-3467,共2页
Hebei Medical Journal
参考文献10
-
1胡盛寿,孔灵芝主编.中国心血管病报告2006.第1版.北京:中国大百科全书出版社,2008.7-10.
-
2急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:851
-
3Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the di- agnosis and treatment of acute and chronic heart failure 2008:the task Force for the diagnosis and treatment of Acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine(ESICM). Eur J Heart Fail, 2008,10 : 933 -989.
-
4Jessup M, Abraham WT, Casey DE, et al. 2009 focused update : ACCF/ AHA Guidelines for the Diagnosis and Management of Heart Failure in A- dults:a report of the American College of Cardiology Foundation/Ameri- can Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplan- tation. Circulation .2009.119: 1977-2016.
-
5Hunt SA,Abrabam WT,Chin MH,et al. ACC/AHA 2005 Guideline Up- date for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College, of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) :developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplanta- tion : endorsed by the Heart Rhythm Society. Circulation, 2005,112 : 154- 235.
-
6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure : executive summary ( update 2005 ) : The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J ,2005,26 : 1115-1140.
-
7李小鹰主编.心血管药理学.第3版.北京:人民卫生出版社,2008.388-425.
-
8Kaojarern S, Day B, Brater DC. The time course of delivery of furosemide into urine:an independent determinant of overall response. Kidney Int, 1982,22:69-74.
-
9Hammarlund MM, Odlind B, Paalzow LK. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Phar- macol Exp Ther, 1985,233:447-453.
-
10陈灏珠.心脏病学.第7版.北京:人民卫生出版社,2007:402.
二级参考文献39
-
1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
-
2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
-
3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
-
4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
-
5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
-
6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
-
7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
-
8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
-
9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
-
10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.
共引文献851
-
1伏继伟.奈西立肽与呋塞米治疗急性心力衰竭的效果及对肿瘤坏死因子样弱凋亡诱导物水平和用药安全的影响[J].中国误诊学杂志,2020(1):1-4.
-
2张蕾.无创呼吸机在急性左心衰竭患者治疗中的应用价值[J].医疗装备,2020,0(4):126-127. 被引量:7
-
3聂国梁.急性心力衰竭患者病情加重的影响因素分析[J].现代诊断与治疗,2023,34(3):323-326. 被引量:2
-
4陈亚君,乔雯雯,薛鸿群.胺碘酮联合环磷腺苷葡胺及琥珀酸美托洛尔治疗急性左心衰伴房颤的疗效及对患者心功能和近期心血管事件的影响分析[J].四川解剖学杂志,2020,0(1):24-25. 被引量:17
-
5田宏,鲁晓玲.美托洛尔联合自拟中药方剂对急性心力衰竭病人血浆NT-proBNP、TNF-α及心功能NYHA分级的影响[J].内蒙古医科大学学报,2018,0(S01):186-189. 被引量:5
-
6李雯,程芳洲,马华,李卫国,江文龙.QRS波时限对肺心病患者短期预后的判断[J].临床心电学杂志,2019,0(5):333-336. 被引量:1
-
7祝绪,廖深根,王凯,郑旭辉,张丽,周艳丽,程思源,陆心怡,李新立.血尿素氮与肌酐比值评估急性心力衰竭患者长期预后的临床价值[J].临床心血管病杂志,2020,36(1):73-78. 被引量:14
-
8田伟,王智彬,刘蕾.米力农联合无创机械通气对重症心力衰竭的疗效分析[J].医药论坛杂志,2021,42(18):57-61. 被引量:1
-
9陈炜,谈晨,张雷,庞庆丰,许美,江华.GDF15、sST2对急性心力衰竭预后的预测价值[J].华南国防医学杂志,2021,35(8):562-565. 被引量:2
-
10陈润真,刘臣,周鹏,盛兆雪,李健楠,周金英,王莹,赵霄潇,陈艺,宋莉,赵汉军,颜红兵.急性心肌梗死患者经皮冠状动脉介入治疗术后心功能与长期预后的关系[J].中华心力衰竭和心肌病杂志(中英文),2020,4(3):159-167. 被引量:16
同被引文献19
-
1赵民生,曹秀虹.利尿剂在治疗心血管疾病时的不良反应及处理[J].药学实践杂志,2006,24(6):353-354. 被引量:6
-
2Grimn RH Jr,Grandits GA,Prinease RJ,et al.Long term effects on sexual funcation of five antihyper-tensive drugs and nutrition hygienic treat- ment of hypertension study[J].Hypertension,1997,29(1):8.
-
3Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update:a report from the American Heart Association I J 1. Circulation, 2010,123 : el 8 -e209.
-
4Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive sum- mary:heart disease and stroke statistics-2010 update: a report from the American Heart Association [ J]. Circulation, 2010, 121:948-954.
-
5Fads R, Flather M, Purcell H, et al. Current evidence sup- porting the role of diuretics in heart failure: a meta analysis of randomised controlled trials [ J ]. Int J Cardiol, 2002,82 ( 2 ) : 149-158.
-
6Fads R,Purcell H,Poole-Wilson PA,et al. Diuretics for heart fail- ure [ J ]. Cochrane Database Syst Rev ,2006, ( 1 ) :3838-3841.
-
7Eshagllian S, Horwich TB, Fonamw GC. Relation of loop diu- retics dose to mortality in advanced heart failure E J ]. Am J Cardio1,2006,97 ( 12 ) : 1759-1764.
-
8Sata Y, Krum H. The future of pharmacological therapy for heart failure [ J ]. Circ J,2010,74 (5) : 809-817.
-
9Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis [ J ]. J Cell Physiol, 2010, 225(3) :631-637.
-
10Dobaczewski M, Bujak M, Li N, et al. Smad3 signaling criti- cally regulates fibroblast phenotype and function in healing myocardial infarction I J ]. Circ Res,2010,107:418-428.
二级引证文献15
-
1卢微.论述心血管内科疾病治疗中利尿剂使用的不良反应[J].世界最新医学信息文摘,2019,0(101):101-101. 被引量:1
-
2刘远林.内外并治治疗慢性心力衰竭伴双下肢水肿患者疗效观察[J].湖北中医杂志,2020(3):36-38. 被引量:1
-
3黄宏佳,张丽筠,林伟泉,郑钰晖.心血管疾病急诊分析及临床治疗方法[J].中国医药科学,2016,6(17):171-173. 被引量:1
-
4付晓芳,陈姣,屈波,唐云.中西医结合治疗慢性心力衰竭伴双下肢水肿临床观察[J].中国中医急症,2017,26(12):2208-2210. 被引量:13
-
5刘汉桃,鲁威.大剂量呋塞米持续静脉泵入治疗重度心力衰竭的效果观察[J].基层医学论坛,2018,22(28):3977-3978. 被引量:5
-
6徐业成.大剂量呋塞米持续静脉泵入治疗重度心衰的效果分析[J].中外医学研究,2019,17(10):20-21. 被引量:5
-
7李银萍,刘志军.钙拮抗剂在心血管疾病患者中的应用效果及不良反应分析[J].基层医学论坛,2019,23(17):2449-2450.
-
8丁茜萍,熊纭辉.重度心力衰竭患者持续静脉泵入大剂量呋塞米的临床疗效观察[J].中国医药科学,2019,9(13):221-223. 被引量:8
-
9段力,尧逢友.温阳化饮益气活血法对急性心肌梗死后早期左室重构大鼠心肌纤维化及肾素-血管紧张素-醛固酮系统激活影响[J].四川中医,2019,37(8):33-36. 被引量:11
-
10杨明.中药强心方对超负荷所致大鼠心力衰竭模型的疗效研究[J].世界中医药,2019,14(7):1681-1685.
-
1治疗重度心衰的新选择[J].当代医学,2001,7(6):14-14.
-
2李建辉,郝国贞.静脉泵入襻利尿剂对肾功能及尿酸的影响[J].现代中西医结合杂志,2014,23(17):1831-1832. 被引量:3
-
3李增男,张军,岳海燕.慢性充血性心力衰竭急性加重期合并低钾血症静脉补钾的体会[J].现代医药卫生,2012,28(1):83-84. 被引量:3
-
4陈桂芬,杨婧,张晓宏,沈丽萍,韩英丽.安体舒通加血管紧张素转换酶抑制剂和襻利尿剂治疗严重慢性心力衰竭的疗效分析[J].中国社区医师,2002,18(1):35-35.
-
5李建辉,郝国贞.静脉泵入襻利尿剂治疗急性心力衰竭伴水肿的研究[J].现代中西医结合杂志,2014,23(14):1495-1497. 被引量:5
-
6管宇,吴学思,徐敏,吴佳慧.襻利尿剂对心力衰竭患者血钠的影响[J].中华心血管病杂志,2014,42(7):582-587. 被引量:3
-
7利尿剂增加高血压患者痛风发生风险[J].浙江中西医结合杂志,2012,22(3):202-202. 被引量:1
-
8张玉英,金跃,马龙乐.联用生脉注射液及巯甲丙脯酸治疗充血性心力衰竭50例疗效观察[J].中西医结合实用临床急救,1998,5(3):126-127.
-
9宋菲,张冬颖,刘剑.利尿剂在心力衰竭中的治疗进展[J].医学综述,2015,21(8):1427-1429. 被引量:17
-
10糖尿病风险随心力衰竭加重而逐步递增[J].药品评价,2014,0(15):6-6.